Abstract
Evaluation of lead compounds for P450 inhibition in human liver microsomes has been widely accepted as an in vitro approach to assess drug interaction potential. This chapter describes a detailed traditional CYP inhibition protocol for six major isoforms: 1A2, 2C9, 2C19, 2D6, 2E1, and 3A4. Microsomal incubation conditions were optimized and kinetic parameters determined to initially establish the inhibition assay. In CYP inhibition assay, separated incubations were performed for individual CYPs, and resulting samples were pooled and analyzed by liquid chromatography/tandem mass spectrometry (LC-MS/MS). It is without doubt that results from this in vitro experiment are of great value in lead optimization in drug discovery and development. It is obvious that more efforts are still needed to establish the relevance between in vitro CYP inhibition and drug interactions in the clinic.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Yan, Z. and Caldwell, G. W. (2001) Metabolism profiling, and cytochrome P450 inhibition and induction in drug discovery. Curr. Top. Med. Chem. 1, 403–425.
Crespi, C. L. and Stresser, D. M. (2001) Fluorometric screening for metabolismbased drug-drug interactions. J. Pharm. Toxicol. Methods 44, 325–331.
Chu, I., Favreau, L., Soares, T., Lin, C. C., and Nomeir, A. A. (2000) Validation of higher-throughput high-performance liquid chromatography/atmospheric pressure chemical ionization tandem mass spectrometry assays to conduct cytochrome P450s CYP2D6 and CYP3A4 enzyme inhibition studies in human liver microsomes. Rapid Comm. Mass Spectr. 14, 207–214.
Prueksaritanont, T., Tang, C., Qiu, Y., Mu, L., Subramanian, R., and Lin, J. H. (2002) Effects of fibrates on metabolism of statins in human hepatocytes. Drug Metab. Dispos. 30, 1280–1287.
Yuan, R., Madani, S., Wei, X. X., Reynolds, K., and Huang, S. M. (2002) Evaluation of cytochrome P450 probe substrates commonly used by the pharmaceutical industry to study in vitro drug interactions. Drug Metab. Dispos. 30, 1311–1319.
Dierks, E. A., Stams, K. R., Lim, H.-K., Cornelius, G., Zhang, H., and Ball, S. E. (2001) A method for the simultaneous evaluation of the activities of seven major human drug-metabolizing cytochrome P450s using an in vitro cocktail of probe substrates and fast gradient liquid chromatography tandem mass spectrometry. Drug Metab. Dispos. 29, 23–29.
Peng, S. X., Barbone, A. G., and Ritchie, D. M. (2003) High-throughput cytochrome P450 inhibition assays by ultrafast gradient liquid chromatography with tandem mass spectrometry using monolithic columns. Rapid Comm. Mass Spectr. 17, 509–518.
Bu, H. Z., Knuth, K., Magis, L., and Teitelbaum, P. (2000) High-throughput cytochrome P450 inhibition screening via cassette probe-dosing strategy: IV. Validation of a direct injection on-line guard cartridge extraction/tandem mass spectrometry method for simultaneous CYP3A4, 2D6 and 2E1 inhibition assessment. Rapid Comm. Mass Spectr. 14, 1943–1948.
Yin, H., Racha, J., Li, S. Y., Olejnik, N., Saton, H., and Moore, D. (2000) Automated high throughput human CYP isoform activity assay using SPE-LC/MS method: application in CYP inhibition evaluation. Xenobiotica 30, 141–154.
Tucker, G. T., Houston, J. B., and Huang, S. M. (2001) Optimizing drug development: strategies to assess drug metabolism/transporter interaction potential-toward a consensus. Pharm. Res. 18, 1071–1080.
Bjornsson, T. D., Callaghan, J. T., Einolf, H. J., Fischer, V., Gan, L., Grimm, S., et al. (2003) The conduct of in vitro and in vivo drug-drug interaction studies: a Pharmaceutical Research and Manufacturers of America (PhRMA) perspective. Drug Metab. Dispos. 31, 815–832.
Ha-Duong, N.-T., Dijols, S., Macherey, A.-C., Goldstein, J. A., Dansette, P. M., and Mansuy, D. (2001) Ticlopidine as a selective mechanism-based inhibitor of human cytochrome P450 2C19. Biochemistry 40, 12,112–12,122.
Palamanda, J. R., Casciano, C. N., Norton, L. A., Clement, R. P., Favreau, L. V., Lin, C.-C., et al. (2001) Mechanism-based inactivation of CYP2D6 by 5-fluoro-2-[4-[(2-phenyl-1H-imidazol-5-yl)methyl]-1-piperazinyl]pyrimidine. Drug Metab. Dispos. 29, 863–867.
Busby, W. F., Jr., Ackermann, J. M., and Crespi, C. L. (1999) Effect of methanol, ethanol, dimethyl sulfoxide, and acetonitrile on in vitro activities of CDNA-expressed human cytochromes P-450. Drug Metab. Dispos. 27, 246–249.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2004 Humana Press Inc., Totowa, NJ
About this protocol
Cite this protocol
Yan, Z., Caldwell, G.W. (2004). Evaluation of Cytochrome P450 Inhibition in Human Liver Microsomes. In: Yan, Z., Caldwell, G.W. (eds) Optimization in Drug Discovery. Methods in Pharmacology and Toxicology. Humana Press. https://doi.org/10.1385/1-59259-800-5:231
Download citation
DOI: https://doi.org/10.1385/1-59259-800-5:231
Publisher Name: Humana Press
Print ISBN: 978-1-58829-332-9
Online ISBN: 978-1-59259-800-7
eBook Packages: Springer Protocols